$0.01—Stale · unknown old
OTCMARKET • Last print unknown ago
$0.01—Stale · unknown old
EVFM News
About
evofem is a biotechnology company focusing on developing innovative reproductive health products for women in every global market. evofem develops and markets products that are woman-controlled, non-invasive and rapidly reversible. women need access to effective products that are well suited to their lifestyle and consistent with their core values. products include: amphora™ - a non-hormonal vaginal gel being investigated for contraceptive and microbicidal properties.
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Saundra Pelletier
Website
Leadership (5)
Saundra PelletierInterim Chair, President & Chief Executive Officer
Amy RaskopfChief Business Development Officer
Ellen ThomasChief of Staff
Ivy ZhangChief Financial Officer & Secretary
Kathy Gallo-DoyleSenior Vice President of Commercial Operations
Explore More
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Strategy Focus List
Continuous multi-factor scoring & catalyst forensics
Market Movers
Today's biggest gainers and losers